Phase 1/2 Randomized Study of the Immunogenicity, Safety, and Tolerability of a Respiratory Syncytial Virus Prefusion F Vaccine in Adults With Concomitant Inactivated Influenza Vaccine

BACKGROUND: Respiratory syncytial virus (RSV) causes substantial morbidity and mortality in older adults and adults with comorbidities. An effective vaccine is needed. An investigational bivalent prefusion F vaccine (RSVpreF) was assessed in healthy adults. METHODS: This phase 1/2 study randomized a...

Descripción completa

Detalles Bibliográficos
Autores principales: Falsey, Ann R, Walsh, Edward E, Scott, Daniel A, Gurtman, Alejandra, Zareba, Agnieszka, Jansen, Kathrin U, Gruber, William C, Dormitzer, Philip R, Swanson, Kena A, Jiang, Qin, Gomme, Emily, Cooper, David, Schmoele-Thoma, Beate
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Major Articles and Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9200152/
https://www.ncbi.nlm.nih.gov/pubmed/34931667
http://dx.doi.org/10.1093/infdis/jiab611

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9200152/
https://www.ncbi.nlm.nih.gov/pubmed/34931667
http://dx.doi.org/10.1093/infdis/jiab611

Ejemplares similares